Indraprastha Medical Corporation Limited Stock Price Today (NSE: INDRAMEDCO)

Indraprastha Medical Corporation Limited

INDRAMEDCOHospital
357.805.25 (1.45%)
Market Closed

Fundamental Score

...

Indraprastha Medical Corporation Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Indraprastha Medical Corporation Limited share price today is 357.80, down 1.45% on NSE/BSE as of 1 September 2026. Indraprastha Medical Corporation Limited (INDRAMEDCO) is a Small-cap company in the Hospital sector with a market capitalisation of 3.46K (Cr). The 52-week high for INDRAMEDCO share price is 640.85 and the 52-week low is 342.00. At a P/E ratio of 18.38x, INDRAMEDCO is currently trading below its industry average P/E of 48.79x. The company has a Return on Equity (ROE) of 27.47% and a debt-to-equity ratio of 0.00.

Indraprastha Medical Corporation Limited Share Price Chart — NSE/BSE Historical Performance

No data
High
405.90
Low
357.80
Volume
6.9L
Change
+1.18%

Indraprastha Medical Corporation Limited share price chart: 1.18% return over the past month. 52-week high ₹640.85, 52-week low ₹342.00.

Indraprastha Medical Corporation Limited — Last 10 Trading Days

DateOpenHighLowCloseVolume
373.00378.00370.00372.951.64L (Cr)
370.00370.95364.95368.951.35L (Cr)
371.50376.00371.00373.401.53L (Cr)
380.00384.20370.10371.901.80L (Cr)
386.05386.05375.30376.952.00L (Cr)
391.00391.00382.20384.353.06L (Cr)
388.00393.15382.05390.755.47L (Cr)
375.00405.90375.00380.6584.74L (Cr)
368.30370.70360.80361.852.21L (Cr)
373.20373.80367.05368.301.09L (Cr)

Indraprastha Medical Corporation Limited — Last 12 Months Price History

MonthOpenHighLowCloseChange
367.00405.90360.80372.95+1.62%
388.05393.40358.25366.35-5.59%
380.45411.00368.60388.05+2.00%
409.65441.00351.20380.35-7.15%
381.60444.00381.60402.05+5.36%
382.40414.40365.00372.35-2.63%
376.00439.00355.30402.05+6.93%
451.00460.45342.00363.15-19.48%
516.50516.50438.10448.10-13.24%
603.00640.85503.80512.50-15.01%
448.85624.70442.65606.45+35.11%
446.15518.11435.85444.80-0.30%

Returns & Performance

Excellent

Return on Equity (ROE)

27.47%

Profit generated per ₹1 of shareholder equity

Excellent

Return on Capital (ROCE)

33.72%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

16.19%

Average operating profit margin over 5 years

Good

Dividend Yield

1.19%

Annual dividend as % of current share price

Indraprastha Medical Corporation Limited Valuation Check

Excellent

Price to Earnings (P/E)

18.38x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

48.79x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

51.00%

% shares held by company founders/management

Poor

FII Holding

2.43%

% shares held by foreign institutional investors

Poor

DII Holding

0.87%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

8.53%

Net profit growth vs same quarter last year

Poor

Revenue Growth (Quarterly YoY)

11.26%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

19.30%

Compounded annual revenue growth over 5 years

Excellent

EPS Growth (5-Year CAGR)

140.30%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

139.52%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.00x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

41.87x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

523.68 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Indraprastha Medical Corporation Limited Fundamental Analysis & Valuation Benchmarking

Educational evaluation of INDRAMEDCO across key market metrics for learning purposes.

Positive Indicators

13 factors identified

Strong Return on Equity (27.47%)

Observation: Efficient use of shareholders' capital generating superior returns.

Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.

Excellent ROCE Performance (33.72%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Strong Operating Margins (16.19%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages.

Attractive Valuation (P/E: 18.38 vs Industry: 48.79)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Consistent Growth Track Record (19.30% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Excellent EPS Growth (140.30% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential.

Strong Profit Growth Track Record (139.52% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Debt-Free Balance Sheet (D/E: 0.00)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (41.87x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Healthy Liquidity Position (Current Ratio: 2.46)

Observation: Strong short-term liquidity to meet obligations.

Analysis: Current ratio >1.5 indicates good working capital management.

Strong Cash Generation (₹523.68 Cr over 5Y)

Observation: Healthy free cash flow generation supports growth and returns.

Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.

Balanced Promoter Holding (51.00%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

1 factors identified

Limited Institutional Interest (FII+DII: 3.30%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

Indraprastha Medical Corporation Limited vs Hospital Peers

Peer Comparison - Hospital

Compare Indraprastha Medical Corporation Limited with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
69.4/100
358
₹3455.15
18.4
Average
27.47%
Excellent
33.72%
Excellent
0.0
Excellent
139.52%
Excellent
19.30%
Excellent
1.19%
62.1/100
8889
₹128448.55
61.5
Average
21.95%
Excellent
19.28%
Good
0.6
Good
66.81%
Excellent
19.03%
Excellent
0.22%
56.9/100
1016
₹107422.79
73.7
Average
14.33%
Average
13.43%
Average
0.3
Excellent
27.30%
Excellent
0.18%
56.8/100
924
₹73687.64
70.3
Average
11.08%
Average
12.83%
Average
0.3
Excellent
17.76%
Excellent
0.10%
37.2/100
765
₹71917.90
225.7
Average
9.70%
Poor
11.35%
Average
0.2
Excellent
21.31%
Excellent
-11.61%
Poor
0.61%
68.3/100
1890
₹41592.95
51.0
Average
19.74%
Good
14.53%
Average
1.1
Average
25.05%
Excellent
0.22%
59.9/100
1404
₹35993.93
64.7
Average
15.15%
Good
16.85%
Good
0.3
Excellent
0.04%
13.9/100
773
₹33947.05
166.0
Average
11.01%
Average
9.35%
Poor
1.4
Average
3.71%
Average
24.04%
Excellent
0.00%
48.5/100
500
₹15618.15
105.3
Average
6.84%
Poor
10.16%
Average
0.1
Excellent
0.00%
65.5/100
1445
₹15270.28
53.5
Average
17.86%
Good
18.10%
Good
0.0
Excellent
0.23%
60/100
299
₹9829.95
52.3
Average
13.41%
Average
15.25%
Good
0.3
Excellent
0.07%

Indraprastha Medical Corporation Limited PE Ratio History

Historical price-to-earnings ratio for INDRAMEDCO — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 202517.56₹448.1025.5x
FY 202413.52₹522.9038.7x
FY 20239.40₹172.4518.3x
FY 20226.39₹83.1013x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Indraprastha Medical Corporation Limited Dividend History

Annual cash dividends paid by INDRAMEDCO — dividend yield 1.19%

Financial YearDividends Paid (₹ Cr)
FY 202540.73 Cr
FY 202427.54 Cr
FY 202322.84 Cr
FY 20220.26 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

Indraprastha Medical Corporation Limited Quarterly Performance

Latest quarterly metrics for INDRAMEDCO — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

11.26%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

8.53%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

19.30%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

139.52%

Compounded annual net profit growth over 5 years

Indraprastha Medical Corporation Limited Technical Indicators

SMA 50, SMA 200, RSI and volume signals for INDRAMEDCO — calculated from daily price history

56RSI 14
Neutral — RSI 56

Momentum is balanced — neither overbought nor oversold.

SMA 50
378
▼ Price below SMA 50 — Short-term bearish
SMA 200
419
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
434K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Indraprastha Medical Corporation Limited Financial Statements

Annual income statement, balance sheet and cash flow for Indraprastha Medical Corporation Limited (INDRAMEDCO) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Indraprastha Medical Corporation Limited

Loading latest quarterly results...

About INDRAMEDCO (Indraprastha Medical Corporation Limited)

Indraprastha Medical Corporation Ltd is a beacon of advanced healthcare nestled in the heart of India, a sprawling complex dedicated to healing and wellness. The hospital's archite...cture blends seamlessly with verdant landscaping, offering patients and visitors a tranquil environment conducive to recovery. Inside, a network of brightly lit corridors connects state-of-the-art diagnostic centers with comfortable, private patient rooms. The air hums with quiet efficiency, a testament to the dedicated team of medical professionals working tirelessly. The aroma of freshly prepared meals wafts from the dietary services, while the gentle murmur of conversations creates a sense of community, reassuring patients that they are not alone on their journey to restored health. INDRAMEDCO distinguishes itself through its unwavering commitment to cutting-edge technology and specialized medical expertise. It houses a vast array of specialized units, each staffed with highly skilled physicians, nurses, and technicians. From the precision of robotic surgery suites to the advanced imaging capabilities of the radiology department, every resource is geared towards providing accurate diagnoses and effective treatments. The hospital boasts specialized clinics dedicated to addressing a wide spectrum of medical needs, ranging from intricate cardiovascular procedures to delicate neurological interventions. Its commitment to research and innovation drives it to continuously refine its treatment protocols, ensuring patients receive the best care. Beyond its impressive medical capabilities, INDRAMEDCO fosters a patient-centric culture rooted in compassion and empathy. The staff is trained to not only address the physical ailments of patients but also to provide emotional support and understanding. Warm smiles and attentive listening are integral parts of the healing process, creating a sense of trust and connection. INDRAMEDCO also emphasizes preventative care, with programs designed to promote healthy lifestyles and reduce the risk of chronic diseases. This holistic approach to healthcare, combined with its commitment to medical excellence, makes INDRAMEDCO a trusted name in healthcare.

Company Details

Symbol:INDRAMEDCO
Industry:Hospital
Sector:Hospital

Key Leadership

Mr. Shivakumar Pattabhiraman ACA, B Com, CWA, Grad.
MD & Additional Director
Mr. Chander Prakash Tyagi
Chief Financial Officer
Mr. Priya Ranjan
Company Secretary & Compliance Officer

Corporate Events

Recent
Ex-Dividend Date

INDRAMEDCO Share Price: Frequently Asked Questions

What is the current share price of Indraprastha Medical Corporation Limited?

Indraprastha Medical Corporation Limited (INDRAMEDCO) trades at ₹357.80 on NSE and BSE. Market cap ₹3.46K (Cr). Educational data only.

What is the P/E ratio of Indraprastha Medical Corporation Limited?

Indraprastha Medical Corporation Limited has a P/E of 18.38x vs industry average 48.79x.

What is the Bull Run score for Indraprastha Medical Corporation Limited?

Indraprastha Medical Corporation Limited has a Bull Run score of 69.4/100 based on 25+ financial parameters.

Does Indraprastha Medical Corporation Limited pay dividends?

Indraprastha Medical Corporation Limited has a dividend yield of 1.19%. Past dividends don't guarantee future payments.

What is the ROE of Indraprastha Medical Corporation Limited?

Indraprastha Medical Corporation Limited has ROE of 27.47%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Indraprastha Medical Corporation Limited?

Indraprastha Medical Corporation Limited has debt-to-equity of 0.00.

Is Indraprastha Medical Corporation Limited a good investment?

Bull Run gives Indraprastha Medical Corporation Limited a score of 69.4/100. This is not investment advice — consult a SEBI-registered advisor.